Countries fail to reach a compromise in TPP talks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Countries fail to reach a compromise in TPP talks

After four days of negotiations, international delegates from 12 countries have failed to reach a compromise over the Trans Pacific Partnership (TPP) Agreement.

The Office of the United States Trade Representative issued a statement yesterday claiming that "substantial progress" has been made in the TPP talks, which are now expected to continue into next year.

The news follows Monday's release by whistleblowing site WikiLeaks of two documents that suggest the US is isolated in its positions on many issues including intellectual property, and is exerting "great pressure" on other countries to comply with its demands.

One of the documents, an internal memo, records "large differences that continue in most areas of the chapter" on intellectual property. It recounts the meeting chair recording solutions "coming from the US position", prompting other countries to demand corrections to the text, which could later be used by the US as a basis for reaching an agreement.

The memo also describes the US proposals on Investor State Dispute Settlement, which allow companies to directly sue governments at a secret international arbitration tribunal, as one of "one of the most significant barriers to closing the chapter" on investment.

The other document, a spreadsheet outlining the positions of the countries on the various issues, shows the US as the sole supporter of proposals such as linkage requirements for pharmaceuticals, the criminalisation of copyright infringement and rules against parallel importation, which was judged to be legal by its own Supreme Court in Kirtsaeng v John Wiley.

The countries involved in the TPP negotiations are Australia, New Zealand, the US, Peru, Chile, Mexico, Canada, Singapore, Brunei, Malaysia, Japan and Vietnam.

Yesterday, six members of US Congress wrote to President Barack Obama arguing that the "secret" negotiations benefit pharmaceutical companies at the expense of public health. The writers, all Democrats, urged the president not to make any final trade agreements "that affect critical health issues" until politicians and members of the public have had the opportunity to review and comment on the proposals.

Joseph Stiglitz, a Nobel prize-winning economist from the Columbia University School of Business, has also written to the negotiators, arguing that several of the proposals would weaken the 2001 Doha Declaration on TRIPS and Public Health.

Separately, 27 organisations and over 70 individuals have signed on to a letter by Knowledge Ecology International protesting the proposal to extend copyright protection to life plus 70 years. The letter argues the extension will result in the loss of countless owned but uncommercialised works and will be "costly to consumers and performers, while benefiting persons and corporate owners that had nothing to do with the creation of the work."

more from across site and SHARED ros bottom lb

More from across our site

New Asia-Pacific IP head Jonathan Chu is eyeing opportunities arising from Chinese technology licensing, overseas enforcement and increasingly IP-heavy cross-border deals
Europe’s largest intellectual property convention and trade fair is back: IP Service World 2026 takes place in Munich from November 23–25 – the 16th edition, with 1,400-plus attendees from 55-plus nations, 100-plus speakers, and 100-plus exhibitors. Three days. Two focused areas. One IP marketplace.
Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
On a recent trip to the French capital, we learned that the UPC is squeezing domestic litigation while firms are chasing senior talent, experimenting with AI and considering new ways of organising their practices
Daniel Law says a string of lateral hires and broader expansion plans will strengthen its position to capitalise on Brazil’s burgeoning IP and patent litigation market
Jason Raeburn’s arrival will expand the firm’s London footprint in AI, copyright and tech disputes
The firm is shaping its AI strategy around partnerships with Harvey and Legora alongside internally developed tools from its legal technology company, Eltemate
Gift this article